We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SAN Sanofi

0.32 (0.37%)
Dec 01 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Sanofi SAN Euronext Ordinary Share
  Price Change Change Percent Stock Price Last Traded
0.32 0.37% 85.78 11:40:00
Open Price Low Price High Price Close Price Prev Close
86.15 85.29 86.48 85.78 85.46
more quote information »

Recent News

Date Time Source Heading
11/30/202309:23DJNTeva Closes Collaboration Deal With Sanofi on IBD Treatment
11/27/202310:31DJNTrending: Sanofi's Notus Trial Meets Primary Endpoint
11/27/202302:40DJNSanofi Says Notus Phase 3 Trial of Dupixent Met Primary..
11/27/202301:30GLOBEDupixent® (dupilumab) Significantly Reduced COPD..
11/23/202312:00GLOBESanofi: Informations relatives au nombre de droits de vote..
11/07/202308:56DJNSanofi Under Preliminary Probe in France Over Possible..
10/30/202308:14DJNMeiraGTx Gets $30 Million Investment From Sanofi
10/27/202311:47DJNSanofi Down Over 19%, on Pace for Record Percent Decrease --..
10/27/202304:43DJNSanofi Shares Tumble After Warning of Profit Hit From..
10/27/202302:54DJNSanofi Backs Guidance After Earnings, Sales Miss Views
10/27/202302:35DJNSanofi Plans to Split Consumer-Healthcare, Pharma Businesses..
10/27/202302:07DJNSanofi Plans to Spin Off Consumer-Healthcare Business
10/27/202301:31GLOBEPress Release: Specialty Care growth, strong launch uptake..
10/27/202301:30GLOBEPress Release: Sanofi Enters Next Chapter of Play to Win..
10/22/202315:00GLOBECommuniqué de presse : Des résultats de phase III relatifs à..
10/22/202314:59GLOBEDupixent® (dupilumab) Phase 3 Results Show Sustained..
10/19/202306:00GLOBEPress Release: Sanofi delivers first medicines from Global..
10/18/202305:40DJNSanofi Says Drug Shows Potential to Slow Diabetes in..
10/18/202304:45GLOBECommuniqué de presse : Des données de ph III présentées au..
10/17/202314:18GLOBESanofi: Information concerning the total number of voting..
10/13/202310:00GLOBECommuniqué de presse : Des données de phase IIb de dernière..
10/06/202302:56DJNSanofi Considering Acquisition of Mirati Therapeutics,..
10/04/202301:57DJNSanofi, Teva Collaborate on Inflammatory Bowel Disease Drug
10/04/202301:00GLOBECommuniqué de presse : Sanofi et Teva annoncent une..
10/03/202302:23DJNSanofi, Janssen Team Up to Develop, Commercialize Vaccine..
10/03/202301:30GLOBEPress Release: Sanofi announces agreement for potential..
9/26/202301:30GLOBECommuniqué de presse : La FDA accorde un examen prioritaire..
9/26/202301:29GLOBEDupixent® (dupilumab) sBLA for Treatment of Eosinophilic..
9/25/202303:00GLOBECommuniqué de presse : ALTUVIIIO® une fois par semaine, une..
9/22/202302:45DJNSanofi Expects Currency Hit to Sales, Earnings
9/22/202301:30GLOBEPress Release: Availability of the Q3 2023 Memorandum for..
9/19/202302:30GLOBECommuniqué de presse : Sanofi soutient les communautés..
9/14/202307:34DJNFirst Wave BioPharma Shares Surge 82% on License Agreement..
9/11/202314:02GLOBESanofi: Information concerning the total number of voting..
8/31/202301:30GLOBEPress Release: Sanofi announces changes to its Executive..
8/15/202315:24GLOBESanofi: Information concerning the total number of voting..
8/04/202303:17DJNSanofi, AstraZeneca RSV Treatment for Infants Gets U.S. CDC..
8/03/202315:21GLOBECommuniqué de presse : Le Comité consultatif des CDC des..
7/28/202307:22GLOBECommuniqué de presse : Mise en ligne du rapport financier..
7/28/202302:21DJNSanofi Raises 2023 Outlook After 2Q Adjusted Earnings Beat..
7/28/202301:32GLOBECommuniqué de presse : Sanofi va acquérir Qunol®, une marque..
7/28/202301:30GLOBEPress Release: Solid Q2 performance and strong pipeline..
7/18/202312:29GLOBESanofi: Informations relatives au nombre de droits de vote..
7/17/202313:00GLOBECommuniqué de presse : La FDA approuve BeyfortusTM..
6/29/202301:30GLOBECommuniqué de presse : Le pipeline Vaccins de Sanofi relève..
6/27/202301:30GLOBEPress Release: Positive topline Phase 2b data in atopic..
6/26/202302:03DJNSanofi Hemophilia Drug Deemed Safe, Effective in Phase 3..
6/25/202310:30GLOBECommuniqué : ALTUVIIIO : des données de dernière heure..
6/22/202301:30GLOBECommuniqué de presse : Mise en ligne du document «Q2 2023..
6/20/202313:43GLOBESanofi: Informations relatives au nombre de droits de vote..

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |